Should You Buy Ceragon Networks Ltd (CRNT) Today? Analysis, Price Targets, and 2026 Outlook.
Conclusion
Hold
Latest Price
2.330
1 Day change
1.75%
52 Week Range
5.520
Analysis Updated At
2026/01/28
CRNT is not a good buy right now for a beginner long-term investor with $50k–$100k. The chart is mildly bullish (moving averages stacked up), but the latest reported quarter shows a sharp deterioration in revenue and profitability (near-zero net income/EPS). With no proprietary buy signals today and earnings coming soon (2026-02-10 pre-market), the risk/reward is not attractive for an impatient long-term entry. Best action: HOLD/WAIT rather than buy now.
Technical Analysis
Trend/structure: Bullish MA stack (SMA_5 > SMA_20 > SMA_200) suggests an upward bias and improving trend structure.
Momentum: RSI(6)=53.4 is neutral (no clear overbought/oversold edge). MACD histogram is slightly above zero (0.000175) but positively contracting, implying the bullish momentum is weakening rather than accelerating.
Levels: Pivot ~2.296 (current ~2.295 is essentially at pivot). Support: S1 2.22 then S2 2.173. Resistance: R1 2.373 then R2 2.42. Near-term setup looks range-bound around the pivot rather than a clean breakout.
Pattern-based projection: Similar-pattern stats imply ~70% chance of a small dip next day (-0.44%), but a modest positive bias over 1 week (+1.19%) and 1 month (+5.54%).
Intellectia Proprietary Trading Signals
- [AI Stock Picker](module://ai_stock_pick): No signal on given stock today.
- [SwingMax](module://swingmax): No signal on given stock recently.
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Sentiment: Extremely call-skewed positioning (put/call OI ratio 0.04; puts OI 1,741 vs calls OI 46,519) indicates bullish/optimistic positioning.
Activity: Options volume is light in absolute terms (51 contracts) and all calls (put volume 0), but volume is elevated vs its 30-day average (today vs avg ~7.13x), suggesting a one-day uptick in bullish interest.
Volatility: IV30 ~64.8 vs HV ~56.8 implies options are pricing somewhat higher future movement than realized recently; IV percentile ~34.8 and IV rank ~9.4 suggest IV is not at extreme highs versus its own history.
Technical Summary
Sell
1
Buy
10
Positive Catalysts
Technicals are constructive (bullish moving averages) and price is holding near the pivot rather than breaking down.
Options positioning is strongly call-leaning, which often aligns with bullish sentiment.
Upcoming earnings (2026-02-10 pre-market) could be a catalyst if results/guide surprise positively (Street EPS est. ~0.03 per calendar data).
Neutral/Negative Catalysts
Latest quarter fundamentals are weak: revenue down sharply YoY and profitability nearly wiped out, which is unfavorable for a long-term beginner-focused buy.
Momentum is not strengthening (MACD histogram positive but contracting; RSI neutral), increasing the odds of chop rather than a clean uptrend.
No recent news catalysts provided and no Intellectia buy signals today, reducing conviction for an immediate entry.
Trading trends: Hedge funds and insiders are neutral (no supportive accumulation signal).
Financial Performance
Latest reported quarter: 2025/Q3.
Revenue: 85.484M, down -16.74% YoY (negative growth trend).
Net income: 0.028M, down -99.77% YoY (profitability collapsed).
EPS: 0, down -100% YoY.
Gross margin: 34.33%, up +0.88% YoY (margin slightly better, but not enough to offset the steep drop in revenue/earnings).
Overall: The quarter shows weakening growth and sharply weaker earnings power, which is not ideal for a long-term beginner buy decision.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating/price target change data was provided, so a recent trend summary cannot be confirmed. Wall Street pro/con view based on available data: Pros—technicals are improving and options sentiment is bullish; Cons—recent quarterly growth and earnings trends are negative and there are no confirmed external endorsements (analyst upgrades/targets) in the supplied dataset. Politician/congress activity: No recent congress trading data available (last 90 days).
Wall Street analysts forecast CRNT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CRNT is 3.25 USD with a low forecast of 3 USD and a high forecast of 3.75 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Analyst Rating
Wall Street analysts forecast CRNT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CRNT is 3.25 USD with a low forecast of 3 USD and a high forecast of 3.75 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Buy
0 Hold
0 Sell
Strong Buy
Current: 2.290
Low
3
Averages
3.25
High
3.75
Current: 2.290
Low
3
Averages
3.25
High
3.75
Roth Capital
Buy
maintain
$4
AI Analysis
2025-08-06
Reason
Roth Capital
Price Target
$4
AI Analysis
2025-08-06
maintain
Buy
Reason
Roth Capital lowered the firm's price target on Ceragon Networks to $3.75 from $4 and keeps a Buy rating on the shares. The company reported "disappointing" Q2 results as key customer in India faced continued headwinds, the analyst tells investors in a research note. The firm lowered second half of 2025 estimates for Ceragon but believes this is the sales trough. The company's North America and private networks are well positioned for 2026, contends Roth.
Roth Capital
Scott Searle
Buy
downgrade
$5 -> $4
2025-07-17
Reason
Roth Capital
Scott Searle
Price Target
$5 -> $4
2025-07-17
downgrade
Buy
Reason
Roth Capital analyst Scott Searle lowered the firm's price target on Ceragon Networks to $4 from $5 and keeps a Buy rating on the shares. India headwinds continue to persist, placing increasing pressure on the firm's 2H25 expectations of a backend-loaded year, the analyst tells investors in a research note. The firm added, however, that the stock's valuation is at trough levels.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for CRNT
